ODI Pharma AB: update – missing MAR label in quarterly report
ODI Pharma AB (“ODI” or “the Company”) gives an update regarding that a MAR label was missing in the quarterly report published 28[th] of May at 15:42 CEST. The updated report – containing a MAR label with reference to the EU´s Market Abuse Regulation – is available as an attached document to this press release and on the company’s website (www.odipharma.com).ODI Pharma AB ODI Pharma, based on its European network, subsidiaries and affiliates, is a producer of finished pharmaceutical cannabis products with a focus on distribution to the medical cannabis market in Europe through its